© 2020 MJH Life Sciences and AJMC. All rights reserved.
© 2020 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
November 15, 2008
Comparison of the generosity and consistency of 10 states' Medicaid preferred drug lists for the top therapeutic classes revealed a large degree of inconsistency.
Adopting quality measurement standards for drug management programs might increase the effectiveness and long-term sustainability of positive health outcomes for patients.
Analysis of Medicare Part D formulary composition since program inception suggests beneficiaries may not be using their open-enrollment periods to reevaluate available plan offerings.
Switching medications for nonmedical (formulary) reasons in long-term care settings may increase Medicare Part D resident adverse effects and raise facility downstream costs.
As a result of Medicare Part D, elderly patients' out-of-pocket costs for prescription drugs decreased and their utilization increased, mostly from 2005-2006.
Primary care physicians have mixed views of prescription drug coverage under Medicare Part D.